{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:39:58Z","timestamp":1789213198346,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"DOI":"10.1038\/s41537-024-00549-y","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:32:04Z","timestamp":1737048724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased mortality risk in people with schizophrenia in Lithuania 2001\u20132020"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4778-3749","authenticated-orcid":false,"given":"Mingaile","family":"Drevinskaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auguste","family":"Kaceniene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunas","family":"Germanavicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-543X","authenticated-orcid":false,"given":"Giedre","family":"Smailyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"549_CR1","doi-asserted-by":"publisher","first-page":"e13094","DOI":"10.1111\/ijcp.13094","volume":"72","author":"J Volavka","year":"2018","unstructured":"Volavka, J. & Vevera, J. Very long-term outcome of schizophrenia. Int. J. Clin. Pract. 72, e13094 (2018).","journal-title":"Int. J. Clin. Pract."},{"key":"549_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","volume":"64","author":"S Saha","year":"2007","unstructured":"Saha, S., Chant, D. & McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch. Gen. Psychiatry 64, 1123\u20131131 (2007).","journal-title":"Arch. Gen. Psychiatry"},{"key":"549_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/wps.20128","volume":"13","author":"E Chesney","year":"2014","unstructured":"Chesney, E., Goodwin, G. M. & Fazel, S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 13, 153\u2013160 (2014).","journal-title":"World Psychiatry"},{"key":"549_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","volume":"4","author":"C Hjorth\u00f8j","year":"2017","unstructured":"Hjorth\u00f8j, C., St\u00fcrup, A. E., McGrath, J. J. & Nordentoft, M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry 4, 295\u2013301 (2017).","journal-title":"Lancet Psychiatry"},{"key":"549_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2017.09.005","volume":"196","author":"EE Lee","year":"2018","unstructured":"Lee, E. E. et al. A widening longevity gap between people with schizophrenia and general population: a literature review and call for action. Schizophr. Res. 196, 9\u201313 (2018).","journal-title":"Schizophr. Res."},{"key":"549_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1359786810385489","volume":"24","author":"R Hodgson","year":"2010","unstructured":"Hodgson, R., Wildgust, H. J. & Bushe, C. J. Cancer and schizophrenia: is there a paradox? J. Psychopharmacol. 24, 51\u201360 (2010).","journal-title":"J. Psychopharmacol."},{"key":"549_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20994","volume":"21","author":"CU Correll","year":"2022","unstructured":"Correll, C. U. et al. Mortality in people with schizophrenia: a systematic review and meta\u2010analysis of relative risk and aggravating or attenuating factors. World Psychiatry 21, 248\u2013271 (2022).","journal-title":"World Psychiatry"},{"key":"549_CR8","unstructured":"Global health risks: mortality and burden of disease attributable to selected major risks [Internet]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789241563871. (2023)."},{"key":"549_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1359786810382149","volume":"24","author":"HJ Wildgust","year":"2010","unstructured":"Wildgust, H. J., Hodgson, R. & Beary, M. The paradox of premature mortality in schizophrenia: new research questions. J. Psychopharmacol. 24, 9\u201315 (2010).","journal-title":"J. Psychopharmacol."},{"key":"549_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.24869\/psyd.2017.108","volume":"29","author":"P Piotrowski","year":"2017","unstructured":"Piotrowski, P. et al. Causes of mortality in schizophrenia: an updated review of European studies. Psychiatr. Danub 29, 108\u2013120 (2017).","journal-title":"Psychiatr. Danub"},{"key":"549_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.schres.2018.04.009","volume":"199","author":"A John","year":"2018","unstructured":"John, A. et al. Premature mortality among people with severe mental illness - New evidence from linked primary care data. Schizophr. Res. 199, 154\u2013162 (2018).","journal-title":"Schizophr. Res."},{"key":"549_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0269881112440512","volume":"26","author":"M Beary","year":"2012","unstructured":"Beary, M., Hodgson, R. & Wildgust, H. J. A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J. Psychopharmacol. 26, 52\u201361 (2012).","journal-title":"J. Psychopharmacol."},{"key":"549_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/schbul\/sbaa137","volume":"47","author":"NCL Yung","year":"2021","unstructured":"Yung, N. C. L., Wong, C. S. M., Chan, J. K. N., Chen, E. Y. H. & Chang, W. C. Excess mortality and life-years lost in people with schizophrenia and other non-affective psychoses: an 11-year population-based cohort study. Schizophr. Bull. 47, 474\u2013484 (2021).","journal-title":"Schizophr. Bull."},{"key":"549_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","volume":"196","author":"S Brown","year":"2010","unstructured":"Brown, S., Kim, M., Mitchell, C. & Inskip, H. Twenty-five year mortality of a community cohort with schizophrenia. Br. J. Psychiatry 196, 116\u2013121 (2010).","journal-title":"Br. J. Psychiatry"},{"key":"549_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-10-77","volume":"10","author":"CK Chang","year":"2010","unstructured":"Chang, C. K. et al. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 10, 77 (2010).","journal-title":"BMC Psychiatry"},{"key":"549_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.schres.2011.07.021","volume":"132","author":"A H\u00f8ye","year":"2011","unstructured":"H\u00f8ye, A., Jacobsen, B. K. & Hansen, V. Increasing mortality in schizophrenia: are women at particular risk? A follow-up of 1111 patients admitted during 1980-2006 in Northern Norway. Schizophr. Res. 132, 228\u2013232 (2011).","journal-title":"Schizophr. Res."},{"key":"549_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","volume":"72","author":"ER Walker","year":"2015","unstructured":"Walker, E. R., McGee, R. E. & Druss, B. G. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72, 334\u2013341 (2015).","journal-title":"JAMA Psychiatry"},{"key":"549_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.20420","volume":"16","author":"CU Correll","year":"2017","unstructured":"Correll, C. U. et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 16, 163\u2013180 (2017).","journal-title":"World Psychiatry"},{"key":"549_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","volume":"170","author":"C Crump","year":"2013","unstructured":"Crump, C., Winkleby, M. A., Sundquist, K. & Sundquist, J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am. J. Psychiatry 170, 324\u2013333 (2013).","journal-title":"Am. J. Psychiatry"},{"key":"549_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1017\/S2045796017000166","volume":"27","author":"J Westman","year":"2018","unstructured":"Westman, J. et al. Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study. Epidemiol. Psychiatr. Sci. 27, 519\u2013527 (2018).","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"549_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/acps.13651","volume":"149","author":"M Drevinskaite","year":"2024","unstructured":"Drevinskaite, M. et al. Cancer mortality and morbidity among patients with schizophrenia: a hospital-based cohort study, 1992-2020. Acta Psychiatr. Scand. 149, 234\u2013243 (2024).","journal-title":"Acta Psychiatr. Scand."},{"key":"549_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1192\/bjp.bp.116.195776","volume":"211","author":"C Zhuo","year":"2017","unstructured":"Zhuo, C., Tao, R., Jiang, R., Lin, X. & Shao, M. Cancer mortality in patients with schizophrenia: systematic review and meta-analysis. Br. J. Psychiatry 211, 7\u201313 (2017).","journal-title":"Br. J. Psychiatry"},{"key":"549_CR23","doi-asserted-by":"crossref","unstructured":"Davis W. A., Bruce D. G., Starkstein S. E., Davis T. M. E. Temporal trends in mortality associated with comorbid Type 2 diabetes and schizophrenia: the fremantle diabetes study. J. Clin. Med.12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9820984\/. 2023[cited 2024 Mar 5].","DOI":"10.3390\/jcm12010300"},{"key":"549_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.genhosppsych.2019.10.007","volume":"61","author":"E Lluch","year":"2019","unstructured":"Lluch, E. & Miller, B. J. Rates of hepatitis B and C in patients with schizophrenia: a meta-analysis. Gen. Hosp. Psychiatry 61, 41\u201346 (2019).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"549_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpsychires.2021.01.050","volume":"136","author":"P Girardi","year":"2021","unstructured":"Girardi, P. et al. Causes of mortality in a large population-based cohort of psychiatric patients in Southern Europe. J. Psychiatr. Res. 136, 167\u2013172 (2021).","journal-title":"J. Psychiatr. Res."},{"key":"549_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/wps.20384","volume":"16","author":"NH Liu","year":"2017","unstructured":"Liu, N. H. et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry 16, 30\u201340 (2017).","journal-title":"World Psychiatry"},{"key":"549_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/acps.12407","volume":"132","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort, D. et al. Promotion of cardiorespiratory fitness in schizophrenia: a clinical overview and meta-analysis. Acta Psychiatr. Scand. 132, 131\u2013143 (2015).","journal-title":"Acta Psychiatr. Scand."},{"key":"549_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.schres.2021.08.022","volume":"237","author":"S Suetani","year":"2021","unstructured":"Suetani, S. et al. Increased rates of respiratory disease in schizophrenia: a systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls. Schizophr. Res. 237, 131\u2013140 (2021).","journal-title":"Schizophr. Res."},{"key":"549_CR29","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.3390\/healthcare10122366","volume":"10","author":"V Peritogiannis","year":"2022","unstructured":"Peritogiannis, V., Ninou, A. & Samakouri, M. Mortality in schizophrenia-spectrum disorders: recent advances in understanding and management. Healthcare. 10, 2366 (2022).","journal-title":"Healthcare."},{"key":"549_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M De Hert","year":"2011","unstructured":"De Hert, M., Detraux, J., van Winkel, R., Yu, W. & Correll, C. U. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat. Rev. Endocrinol. 8, 114\u2013126 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"549_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/wps.20699","volume":"19","author":"H Taipale","year":"2020","unstructured":"Taipale, H. et al. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry 19, 61\u201368 (2020).","journal-title":"World Psychiatry"},{"key":"549_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/schbul\/sbab087","volume":"48","author":"M Solmi","year":"2022","unstructured":"Solmi, M. et al. Antipsychotics use is associated with greater adherence to cardiometabolic medications in patients with schizophrenia: results from a nationwide, within-subject design study. Schizophr. Bull. 48, 166\u2013175 (2022).","journal-title":"Schizophr. Bull."},{"key":"549_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fpsyt.2018.00463","volume":"9","author":"S Barber","year":"2018","unstructured":"Barber, S. & Thornicroft, G. Reducing the mortality gap in people with severe mental disorders: the role of lifestyle psychosocial interventions. Front. Psychiatry 9, 463 (2018).","journal-title":"Front. Psychiatry"},{"key":"549_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/da.23222","volume":"39","author":"ST Wilkinson","year":"2022","unstructured":"Wilkinson, S. T. et al. Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis. Depress Anxiety 39, 100\u2013112 (2022).","journal-title":"Depress Anxiety"},{"key":"549_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S2215-0366(19)30414-6","volume":"7","author":"M Solmi","year":"2020","unstructured":"Solmi, M. et al. Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4\u2008717\u2008839 people. Lancet Psychiatry 7, 52\u201363 (2020).","journal-title":"Lancet Psychiatry"},{"key":"549_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1176\/appi.ajp.2021.21010031","volume":"178","author":"M Solmi","year":"2021","unstructured":"Solmi, M. et al. Disparities in screening and treatment of cardiovascular diseases in patients with mental disorders across the world: systematic review and meta-analysis of 47 observational studies. Am. J. Psychiatry 178, 793\u2013803 (2021).","journal-title":"Am. J. Psychiatry"},{"key":"549_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00127-008-0481-3","volume":"44","author":"A Arvaniti","year":"2009","unstructured":"Arvaniti, A. et al. Health service staff\u2019s attitudes towards patients with mental illness. Soc. Psychiatry Psychiatr. Epidemiol. 44, 658\u2013665 (2009).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"549_CR38","unstructured":"Metiniai mirties prie\u017eas\u010di\u0173 duomenys [Internet]. Available from: https:\/\/www.hi.lt\/mirties-priezasciu-statistika-metiniai-mirties-priezasciu-duomenys\/. [cited 2024 Nov 29]."}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-024-00549-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-024-00549-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-024-00549-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:32:08Z","timestamp":1737048728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-024-00549-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1038\/s41537-024-00549-y","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the authors did not use any generative AI or AI-assisted technologies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Vilnius regional biomedical research ethics committee (approval number No. 2022\/6-1449-915 on 14 June 2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients\u2019 consent was waived to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"7"}}